Clinical Trial Update: Sym004 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for Sym004 in patients with metastatic colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Sym004

Snippet

Sponsor: Symphogen A/S | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-12